These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19085270)

  • 1. Normal dopaminergic nigrostriatal innervation in SPG3A hereditary spastic paraplegia.
    Albin RL; Koeppe RA; Rainier S; Fink JK
    J Neurogenet; 2008; 22(4):289-94. PubMed ID: 19085270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early onset autosomal dominant spastic paraplegia caused by novel mutations in SPG3A.
    Abel A; Fonknechten N; Hofer A; Dürr A; Cruaud C; Voit T; Weissenbach J; Brice A; Klimpe S; Auburger G; Hazan J
    Neurogenetics; 2004 Dec; 5(4):239-43. PubMed ID: 15517445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Four novel SPG3A/atlastin mutations identified in autosomal dominant hereditary spastic paraplegia kindreds with intra-familial variability in age of onset and complex phenotype.
    Smith BN; Bevan S; Vance C; Renwick P; Wilkinson P; Proukakis C; Squitieri F; Berardelli A; Warner TT; Reid E; Shaw CE
    Clin Genet; 2009 May; 75(5):485-9. PubMed ID: 19459885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mutations in the Atlastin gene (SPG3A) in families with autosomal dominant hereditary spastic paraplegia and evidence for late onset forms of HSP linked to the SPG3A locus.
    Sauter SM; Engel W; Neumann LM; Kunze J; Neesen J
    Hum Mutat; 2004 Jan; 23(1):98. PubMed ID: 14695538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel mutation in the SPG3A gene in an African American family with an early onset of hereditary spastic paraplegia.
    Hedera P; Fenichel GM; Blair M; Haines JL
    Arch Neurol; 2004 Oct; 61(10):1600-3. PubMed ID: 15477516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPG3A mutation screening in English families with early onset autosomal dominant hereditary spastic paraplegia.
    Wilkinson PA; Hart PE; Patel H; Warner TT; Crosby AH
    J Neurol Sci; 2003 Dec; 216(1):43-5. PubMed ID: 14607301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPG3A-linked hereditary spastic paraplegia associated with cerebral glucose hypometabolism.
    Terada T; Kono S; Ouchi Y; Yoshida K; Hamaya Y; Kanaoka S; Miyajima H
    Ann Nucl Med; 2013 Apr; 27(3):303-8. PubMed ID: 23233086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary spastic paraplegia: identification of an SPG3A gene mutation in a Chinese family.
    Chan KY; Ching CK; Mak CM; Lam CW; Chan AY
    Hong Kong Med J; 2009 Aug; 15(4):304-7. PubMed ID: 19652243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and genetic characterization of hereditary spastic paraplegia type 3A in Taiwan.
    Hsu SL; Hsueh HW; Chen SY; Chang YY; Tan S; Hong CT; Tsai YS; Yu KW; Wu HM; Liao YC; Soong BW; Hu CJ; Lan MY; Lee YC
    Parkinsonism Relat Disord; 2021 Jun; 87():87-91. PubMed ID: 34015694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary spastic paraplegia and axonal motor neuropathy caused by a novel SPG3A de novo mutation.
    Fusco C; Frattini D; Farnetti E; Nicoli D; Casali B; Fiorentino F; Nuccitelli A; Giustina ED
    Brain Dev; 2010 Aug; 32(7):592-4. PubMed ID: 19735987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation analysis of SPG4 and SPG3A genes and its implication in molecular diagnosis of Korean patients with hereditary spastic paraplegia.
    Park SY; Ki CS; Kim HJ; Kim JW; Sung DH; Kim BJ; Lee WY
    Arch Neurol; 2005 Jul; 62(7):1118-21. PubMed ID: 16009769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of HSP-causing mutations in SPG3A and NIPA1 on the assembly, trafficking, and interaction between atlastin-1 and NIPA1.
    Botzolakis EJ; Zhao J; Gurba KN; Macdonald RL; Hedera P
    Mol Cell Neurosci; 2011 Jan; 46(1):122-35. PubMed ID: 20816793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mutation in the SPG3A gene (atlastin) in hereditary spastic paraplegia.
    Matsui M; Kawarai T; Hase Y; Tomimoto H; Iseki K; Rogaeva E; Orlacchio A; Bernardi G; St George-Hyslop P; Takahashi R; Matsui M
    J Neurol; 2007 Jul; 254(7):972-4. PubMed ID: 17380240
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel mutation in the ATL1 with autosomal dominant hereditary spastic paraplegia presented as dysautonomia.
    Shin JW; Jung KH; Lee ST; Moon J; Seong MW; Park SS; Lee SK; Chu K
    Auton Neurosci; 2014 Oct; 185():141-3. PubMed ID: 24969372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex phenotype in an Italian family with a novel mutation in SPG3A.
    de Leva MF; Filla A; Criscuolo C; Tessa A; Pappatà S; Quarantelli M; Bilo L; Peluso S; Antenora A; Longo D; Santorelli FM; De Michele G
    J Neurol; 2010 Mar; 257(3):328-31. PubMed ID: 19768483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and genetic analysis of a Korean family with hereditary spastic paraplegia type 3.
    Kwon MJ; Lee ST; Kim JW; Sung DH; Ki CS
    Ann Clin Lab Sci; 2010; 40(4):375-9. PubMed ID: 20947813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPG3A protein atlastin-1 is enriched in growth cones and promotes axon elongation during neuronal development.
    Zhu PP; Soderblom C; Tao-Cheng JH; Stadler J; Blackstone C
    Hum Mol Genet; 2006 Apr; 15(8):1343-53. PubMed ID: 16537571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic rescue of axon growth defects in a human iPSC model of hereditary spastic paraplegia SPG3A.
    Zhu PP; Denton KR; Pierson TM; Li XJ; Blackstone C
    Hum Mol Genet; 2014 Nov; 23(21):5638-48. PubMed ID: 24908668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SPG3A: An additional family carrying a new atlastin mutation.
    Tessa A; Casali C; Damiano M; Bruno C; Fortini D; Patrono C; Cricchi F; Valoppi M; Nappi G; Amabile GA; Bertini E; Santorelli FM
    Neurology; 2002 Dec; 59(12):2002-5. PubMed ID: 12499504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPG3A is the most frequent cause of hereditary spastic paraplegia with onset before age 10 years.
    Namekawa M; Ribai P; Nelson I; Forlani S; Fellmann F; Goizet C; Depienne C; Stevanin G; Ruberg M; Dürr A; Brice A
    Neurology; 2006 Jan; 66(1):112-4. PubMed ID: 16401858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.